secwatch / observer
8-K filed January 23, 2026, 6:59 PM ET ticker CLBZ CIK 0002050338
other material confidence high sentiment neutral materiality 0.60

Collab Z enters $5M Series C convertible preferred financing contingent on IPO by Sept 30, 2026

Collab Z Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-007244
form_type
8-K
ticker
CLBZ
cik
0002050338
company_name
Collab Z Inc.
filed_at
2026-01-23T23:59:59+00:00
discovered_at
2026-05-14T18:02:37.119074+00:00
generated_at
2026-05-16T08:35:29.668125+00:00
sec_items
["1.01", "2.03", "3.02", "5.03", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.6
calibrated_materiality_score
0.6
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-007244
json_url
https://secwatch.observer/filing/0001213900-26-007244.json
markdown_url
https://secwatch.observer/filing/0001213900-26-007244.md
text_url
https://secwatch.observer/filing/0001213900-26-007244.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2050338/000121390026007244/0001213900-26-007244-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2050338/000121390026007244/ea0273795-8k_collab.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

cd161be544c67fdb0af6384234ef59b8d58d293b

Collab Z Inc.: Filed Certificate of Designation for Series C Convertible Preferred Stock, establishing terms of the series (effective 2026-01-23).

The Certificate of Designation was filed with the State of Nevada Secretary of State on January 23, 2026.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

b071b0246a3aaa06a5ad65bbba9bf2f72fb97b61

Collab Z Inc. entered into Securities Purchase Agreement with certain accredited investors valued at Five Million Dollars ($5,000,000) (effective 2026-01-19).

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.03, 9.01 same event type: other_material similar materiality

This filing

The Certificate of Designation was filed with the State of Nevada Secretary of State on January 23, 2026.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

The Certificate of Designation was filed with the State of Nevada Secretary of State on January 23, 2026.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

The Certificate of Designation was filed with the State of Nevada Secretary of State on January 23, 2026.

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

TPST

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

Comparable filing

On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock

Filing page SEC filing

CITR

CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights

CitroTech Inc. June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

Comparable filing

On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock

Filing page SEC filing

PBT

Court approves trust indenture amendments eliminating 75% supermajority requirement

PERMIAN BASIN ROYALTY TRUST May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

Comparable filing

Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.

Filing page SEC filing

AIM

AIM ImmunoTech expects ~$4.2M gross from warrant inducement at $0.48/share; new warrants at $0.60

AIM ImmunoTech Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

Comparable filing

On May 7, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a warrant exercise inducement offer letter agreement (the “Inducement Letter”) with holders (the “Holders”) of (i) Class A and Class B common stock purchase warrants issued on May 31, 2024

Filing page SEC filing

VTIX

Virtuix amends warrants to $4.00 exercise price, extends period to July 27, 2026

Virtuix Holdings Inc. June 2, 2026, 9:15 AM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 9.01 same event type: other_material similar materiality

This filing

On January 19, 2026, Collab Z Inc. (the “Company”) executed securities purchase agreements (the “Securities Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”), up to (i) 1,250,000 shares (the “Shares”) of the Company’s newly-designated Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C”), at a price per share of $4.00, for an aggregate of up to Five Million Dollars ($5,000,000) (the “Purchase Price”).

Comparable filing

On June 1, 2026, Virtuix Holdings Inc. (the “Company”) entered into amendments to each of the following warrants to purchase shares of Class A Common Stock (collectively, the “Warrant Amendments”) with Streeterville Capital, LLC (the “Investor”) amending the exercise price and extending the Reduced Exercise Price Period (as defined below) to each such warrant

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-007244

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.